These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9154397)

  • 1. The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study.
    Vermeer BJ; Staats CC
    Dermatology; 1997; 194 Suppl 1():22-4. PubMed ID: 9154397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel.
    Faergemann J; Hersle K; Nordin P
    Dermatology; 1997; 194 Suppl 1():19-21. PubMed ID: 9154396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week terbinafine 1% solution in pityriasis versicolor: twice-daily application is more effective than once-daily.
    Budimulja U; Paul C
    J Dermatolog Treat; 2002 Mar; 13(1):39-40. PubMed ID: 12006138
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial.
    Schopf R; Hettler O; Bräutigam M; Weidinger G; Kaben U; Mayser P; Resl V
    Mycoses; 1999; 42(5-6):415-20. PubMed ID: 10536434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor.
    Aste N; Pau M; Pinna AL; Colombo MD; Biggio P
    Mycoses; 1991; 34(7-8):353-7. PubMed ID: 1803242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M; Evans C; Muddle A; Turner R; Lim S; Reed J; Traynor M
    Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinea versicolor treated with terbinafine 1% solution.
    Savin R; Eisen D; Fradin MS; Lebwohl M
    Int J Dermatol; 1999 Nov; 38(11):863-5. PubMed ID: 10583623
    [No Abstract]   [Full Text] [Related]  

  • 9. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.
    James IG; Loria-Kanza Y; Jones TC
    J Dermatolog Treat; 2007; 18(3):163-8. PubMed ID: 17538805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
    Li RY; Wang AP; Xu JH; Xi LY; Fu MH; Zhu M; Xu ML; Li XQ; Lai W; Liu WD; Lu XY; Gong ZQ
    Clin Drug Investig; 2014 Mar; 34(3):223-30. PubMed ID: 24477462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Malassezia furfur subgroups to terbinafine.
    Leeming JP; Sansom JE; Burton JL
    Br J Dermatol; 1997 Nov; 137(5):764-7. PubMed ID: 9415238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
    Lange DS; Richards HM; Guarnieri J; Humeniuk JM; Savin RC; Reyes BA; Hickman J; Pariser DM; Pariser RJ; Sherertz EF; Grossman RM; Gisoldi EM; Klausner MA
    J Am Acad Dermatol; 1998 Dec; 39(6):944-50. PubMed ID: 9843006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor].
    Corte M; Jung K; Linker U; Martini H; Sapp-Boncelet I; Schulz H
    Mycoses; 1989 Apr; 32(4):200-3. PubMed ID: 2755466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can pityriasis versicolor be treated with 2% ketoconazole foam?
    Cantrell WC; Elewksi BE
    J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tinea corporis/cruris: new treatment options.
    van Heerden JS; Vismer HF
    Dermatology; 1997; 194 Suppl 1():14-8. PubMed ID: 9154395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.